👉 The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms

👉 Check out our latest publication on The Lancet Gastroenterology & Hepatology from the Verona EBM 2020 on IPMN consortium

🆓 full text !
sciencedirect.com/science/articl…

🔥 Hot off the press

Postoperative Serum #Hyperamylasemia (POH) Adds Sequential Value to the #Fistula Risk Score (FRS) in Predicting Pancreatic Fistula after #Pancreatoduodenectomy

👉 Out now in Annals of Surgery

journals.lww.com/annalsofsurger…

IHPBA and the IHPBA Foundation are delighted to announce the winners of the 2022/23 Kenneth Warren Fellowships
🌟Dr Samuel Cannas, Università di Pisa, Italy
🌟Dr Elisabetta Sereni,
Pancreas Verona

🔗Read more here: ihpba.org/news/512/2022-…

🔴 The quantum physics of intraductal papillary mucinous neoplasm of the pancreas 🔴

Read our last paper on BJS Open

Free full text!
academic.oup.com/bjsopen/articl…

It was a great experience in Belgrade 🇷🇸 for the 14th EDS postgraduate course

🔝 educational and learning experience EDS Belgrade 2022 🔥Thanks to all our colleagues who made it possible

Second event of the day 🏍🏍🏍

We ride with Massimo, cancer warrior, and cut the line together 🏁

And we even enjoyed a classic “piadina” from Romagna 🇮🇹

WHAT A DAY!

Today we celebrate #research #hope and #sport as a cure of #PancreaticCancer

🚴 The first event is a bike ride to Padova with Massimo and team

Thank you Fondazione Nadia Valsecchi Onlus for the support!

Stay tuned for more !!! 🏍👍👍👍

🏍 On May 25th we will be hosting a very special event with one of our patient as the protagonist 🏍

Stay tuned for more!!!

Io Vado al Massimo # Bike 🚴

Progetto di Sensibilizzazione sui Tumori del #Pancreas , da Torino a Venezia 🚲

Ospiteremo l’evento il 25 Maggio a Verona! youtube.com/watch?v=tRKdJX…

Bioethics in an oncological surgery unit during the #COVID19 pandemic: the Verona experience

link.springer.com/article/10.100…

Pure Biliary Leak vs. Pancreatic Fistula associated: Non-identical twins following Pancreatoduodenectomy - ScienceDirect

⁦@HPBjournal⁩ ⁦Ernesto Sparrelid⁩ ⁦Karolinska-HPB⁩ ⁦Karolinska Institutet⁩ ⁦Università di Verona⁩ 🇮🇹 🇸🇪 sciencedirect.com/science/articl…

Check out our new paper on SURGERY Journal categorizing #mortality after PD!!

🟢A—> 📉late decline due to pancreas specific complications
🔴B—> 🩸critical illness right after OR (surgical complexity?!)
🔵C—> ⚡️sudden deaths

A novel tool for comparison and #benchmarking ??

On behalf of the entire EDS Council, we would like to offer our support and solidarity to our Ukrainian friends during these difficult times.

Any EDS member in need of medical aid in terms of materials and/or human resources can approach us at [email protected]
EDS Council

The faith of non-surveilled pancreatic cysts: a bicentric retrospective study

Giovanni Marchegiani Stefano Andrianello Tommaso Pollini Martin Schindl MedUni Wien Pancreas Verona YOUPPIE Pancreas E-AHPBA European Society of Surgical Oncology (ESSO)

#some4surgery 🍇

bit.ly/3H0DiAx

Thank you Society of Surgical Oncology for selecting our paper on AnnalsSurgOncology 🙏

Hope it will improve the decision making in patients with IPMN who are potential candidates for surgery 💪

my_UEG smartphone application
Want to follow guidelines on pancreatic cystic neoplasms? @uegjournal
👉 iCyst app
✅ Cool scenarios, highly helpful
Alberto Balduzzi Pancreas Verona Philip Müller Giovanni Marchegiani @SoMe4Surgery Kjetil Søreide IHPBA

onlinelibrary.wiley.com/doi/full/10.10…

401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience

Out now on Surgical Endoscopy

link.springer.com/article/10.100…

Our last paper with Ospedale San Raffaele published in the AnnalsSurgOncology is on the risk assessment of surgery for IPMN

Age, overweight and diabetes are factors tipping the scale for decision making once no overt cancer presence is found

It is a 🆓 full text !!!

Survival calculator after #pancreatoduodenectomy for distal #cholangiocarcinoma , developed in 752 pts from 🇳🇱 🇧🇪 🇮🇹 🇬🇧: 3 risk groups with 3-year OS 65.4%, 33.2% and 11.8%. see Pancreascalculator.com and nature.com/articles/s4141… #SoMe4HPB #pancreas